Standard BioTools Inc LAB
News
Standard BioTools proteomics profiling reveals unique biomarkers and insights into nonalcoholic steatohepatitis (NASH)
Standard BioTools to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
Standard BioTools to Participate in Upcoming Investor Conferences
Standard BioTools Announces Senior Leadership Changes
Standard BioTools Reports Second Quarter 2024 Financial Results
Standard BioTools Announces Conference Call and Webcast for Second Quarter 2024 Financial Results on July 31, 2024
SomaLogic's stock surges as it agrees to be bought by Standard BioTools in all-stock merger